My bad partner "Immunocore’s specialty, however, has been working in oncology. Its therapies induced industry giants including AstraZeneca (NYSE:AZN), Eli Lilly (NYSE:LLY), GSK (NYSE:GSK) and Genentech to partner with the biotech over the years."
you are viewing a single comment's thread
view the rest of the comments
view the rest of the comments
replies: